In the past week, big insider buying followed secondary offerings from Immunovant Inc. (NASDAQ: IMVT), Kymera Therapeutics Inc. (NASDAQ: KYMR), and Wave Life Sciences Ltd. (NASDAQ: WVE). Kenvue Inc. (NYSE: KVUE) saw a major insider purchase after news of its acquisition. Other notable insider purchases were also reported recently.

Insider buying is seen as a positive signal, indicating insiders believe the stock price will rise. Notable recent purchases include Roivant Sciences acquiring almost 16.7 million shares, Baker Bros. Advisors buying over 2 million shares, and a director purchasing nearly 6.4 million shares.

Immunovant, Kymera, and Wave Life Sciences saw significant stock movements after insider purchases and public offerings. Analysts forecast further upside for these companies, with positive recommendations for buying shares. However, some directors sold shares earlier in the month.

A recent study revealed a single habit that can double Americans’ retirement savings, unrelated to income or lifestyle changes. This habit has significant impact but is simple and easy to adopt, yet many do not utilize it.

Recent insider purchases were also reported for companies like Seven Hills Realty Trust, Middleby Corp., and Walt Disney Co. These purchases, along with others, indicate continued confidence in certain businesses.

Read more at Yahoo Finance: Share Offerings Prompt Huge Insider Buying in These 3 Biotechs